Gadolinium

"Gadolinium" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

An element of the rare earth family of metals. It has the atomic symbol Gd, atomic number 64, and atomic weight 157.25. Its oxide is used in the control rods of some nuclear reactors.

Descriptor ID	D005682
MeSH Number(s)	D01.268.558.362.484 D01.552.550.399.484
Concept/Terms	Gadolinium Gadolinium

Below are MeSH descriptors whose meaning is more general than "Gadolinium".

Chemicals and Drugs [D]
Inorganic Chemicals [D01]
Elements [D01.268]
Metals, Rare Earth [D01.268.558]
Lanthanoid Series Elements [D01.268.558.362]
Gadolinium [D01.268.558.362.484]
Metals [D01.552]
Metals, Rare Earth [D01.552.550]
Lanthanoid Series Elements [D01.552.550.399]
Gadolinium [D01.552.550.399.484]

Below are MeSH descriptors whose meaning is related to "Gadolinium".

Below are MeSH descriptors whose meaning is more specific than "Gadolinium".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Gadolinium" by people in this website by year, and whether "Gadolinium" was a major or minor topic of these publications.

Bar chart showing 68 publications over 25 distinct years, with a maximum of 7 publications in 2012

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
1995	2	0	2
1997	1	1	2
2001	1	0	1
2002	0	1	1
2004	1	1	2
2006	2	0	2
2007	1	2	3
2008	3	3	6
2009	1	3	4
2010	2	1	3
2011	3	1	4
2012	4	3	7
2013	0	1	1
2014	4	2	6
2015	2	0	2
2016	3	0	3
2017	2	2	4
2018	1	2	3
2019	0	1	1
2020	0	2	2
2021	1	1	2
2022	1	2	3
2023	0	2	2
2024	0	1	1
2025	1	0	1

Below are the most recent publications written about "Gadolinium" by people in Profiles.

Al Gburi M, Mazzola M, Absinta M, Gait?n MI, Reich DS, Dundamadappa SK, Hemond CC. Paramagnetic rim lesion formation is predicted by the initial gadolinium-enhancing lesion diameter. Mult Scler. 2025 Mar; 31(3):263-277.

View in: PubMed
Chan RH, van der Wal L, Liberato G, Rowin E, Soslow J, Maskatia S, Chan S, Shah A, Fogel M, Hernandez L, Anwar S, Voges I, Carlsson M, Buddhe S, Laser KT, Greil G, Valsangiacomo-Buechel E, Olivotto I, Wong D, Wolf C, Grotenhuis H, Rickers C, Hor K, Rutz T, Kutty S, Samyn M, Johnson T, Hasbani K, Moore JP, Sieverding L, Detterich J, Parra R, Chungsomprasong P, Toro-Salazar O, Roest AAW, Dittrich S, Brun H, Spinner J, Lai W, Dyer A, Jablonowsk R, Meierhofer C, Gabbert D, Prsa M, Patel JK, Hornung A, Diab SG, House AV, Rakowski H, Benson L, Maron MS, Grosse-Wortmann L. Myocardial Scarring and Sudden Cardiac Death in Young Patients With Hypertrophic Cardiomyopathy: A Multicenter Cohort Study. JAMA Cardiol. 2024 Nov 01; 9(11):1001-1008.

View in: PubMed
Chitnis T, Foley J, Ionete C, El Ayoubi NK, Saxena S, Gaitan-Walsh P, Lokhande H, Paul A, Saleh F, Weiner H, Qureshi F, Becich MJ, da Costa FR, Gehman VM, Zhang F, Keshavan A, Jalaleddini K, Ghoreyshi A, Khoury SJ. Clinical validation of a multi-protein, serum-based assay for disease activity assessments in multiple sclerosis. Clin Immunol. 2023 08; 253:109688.

View in: PubMed
Fahmy AS, Rowin EJ, Jaafar N, Chan RH, Rodriguez J, Nakamori S, Ngo LH, Pradella S, Zocchi C, Olivotto I, Manning WJ, Maron M, Nezafat R. Radiomics of Late Gadolinium Enhancement Reveals Prognostic Value?of Myocardial Scar Heterogeneity in Hypertrophic Cardiomyopathy. JACC Cardiovasc Imaging. 2024 01; 17(1):16-27.

View in: PubMed
Heydari B, Satriano A, Jerosch-Herold M, Kolm P, Kim DY, Cheng K, Choi YL, Antiochos P, White JA, Mahmod M, Chan K, Raman B, Desai MY, Ho CY, Dolman SF, Desvigne-Nickens P, Maron MS, Friedrich MG, Schulz-Menger J, Piechnik SK, Appelbaum E, Weintraub WS, Neubauer S, Kramer CM, Kwong RY. 3-Dimensional Strain Analysis of?Hypertrophic Cardiomyopathy: Insights From the NHLBI International HCM Registry. JACC Cardiovasc Imaging. 2023 04; 16(4):478-491.

View in: PubMed
Fahmy AS, Rowin EJ, Arafati A, Al-Otaibi T, Maron MS, Nezafat R. Radiomics and deep learning for myocardial scar screening in hypertrophic cardiomyopathy. J Cardiovasc Magn Reson. 2022 06 27; 24(1):40.

View in: PubMed
Mancio J, Pashakhanloo F, El-Rewaidy H, Jang J, Joshi G, Csecs I, Ngo L, Rowin E, Manning W, Maron M, Nezafat R. Machine learning phenotyping of scarred myocardium from cine in hypertrophic cardiomyopathy. Eur Heart J Cardiovasc Imaging. 2022 03 22; 23(4):532-542.

View in: PubMed
Rowin EJ, Maron MS, Adler A, Albano AJ, Varnava AM, Spears D, Marsy D, Heitner SB, Cohen E, Leong KMW, Winters SL, Martinez MW, Koethe BC, Rakowski H, Maron BJ. Importance of newer cardiac magnetic resonance-based risk markers for sudden death prevention in hypertrophic cardiomyopathy: An international multicenter study. Heart Rhythm. 2022 05; 19(5):782-789.

View in: PubMed
Fahmy AS, Rowin EJ, Chan RH, Manning WJ, Maron MS, Nezafat R. Improved Quantification of Myocardium Scar in Late Gadolinium Enhancement Images: Deep Learning Based Image Fusion Approach. J Magn Reson Imaging. 2021 07; 54(1):303-312.

View in: PubMed
Habib M, Adler A, Fardfini K, Hoss S, Hanneman K, Rowin EJ, Maron MS, Maron BJ, Rakowski H, Chan RH. Progression of Myocardial Fibrosis in Hypertrophic Cardiomyopathy: A Cardiac Magnetic Resonance Study. JACC Cardiovasc Imaging. 2021 05; 14(5):947-958.

View in: PubMed

People

Explore

Similar Concepts

Top Journals